STAT+: AstraZeneca and Ionis detail surprise failure of heart disease drug, with Alnylam closely watching
STAT News · LC · trust 42/100
Roivant's autoimmune drug approval, Cytokinetics reports full data for heart condition treatment, and more biotech news
Read the original at STAT News →
Open in TruthVane →